drugset / Trial / NCT06163352

The Effect of Vasopressor on Pressure Injury Development

NCT06163352

Completed 148 enrolled Koç University
Non-randomizedParallel-groupOpen-labelHealth-services research

Summary

Background: Vasopressors are life-saving agents that increase mean arterial pressure. The pharmacodynamic features of these agents and previous studies suggest that vasopressors may be an essential risk factor in developing pressure injuries. Objective: This study aimed to examine the effect of vasopressors in medical-surgical intensive care patients on pressure injury development. Design and Settings: This retrospective and correlational study was conducted between March 2021- May 2022. The electronic patient data were obtained from 148 surgical and medical patients treated with vasopressor agents in the intensive care unit. Data on patients' demographic and clinical characteristics were evaluated using descriptive statistical methods (number, percentage, mean, standard deviation). A logistic regression model was established to estimate the dependent variable (development of pressure injury) with the independent variables.

Timeline

Start
2023-05-01
Primary completion
2023-08-01
Completion
2023-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified

Indications